This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
OMNIPAQUE 240
GE HEALTHCARE CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is OMNIPAQUE 240 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that OMNIPAQUE 240 518MG has been permanently discontinued (last updated March 18, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is OMNIPAQUE 240 not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02172739
Strength
518MG
Dosage Form
SOLUTION
Route
INTRAVASCULAR SUBARACHNOIDAL
Active Ingredient
IOHEXOL
Tier
Unrated
Last Updated
2022-05-20
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
OMNIPAQUE 240 has 6 shortage/discontinuation reports on file — this is one of them.
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.